Coronavirus | In talks with Indian govt. for clinical trial of single shot vaccine: Johnson & Johnson - The Hindu

The U.S. Food and Drug Administration has already approved Johnson & Johnson's COVID-19 vaccine that works with just one dose for emergency use in FebruaryGlobal healthcare major Johnson & Johnson is in discussions with the Indian government to begin a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Friday.

The U.S. Food and Drug Administration has already approved Johnson & Johnson's COVID-19 vaccine that works with just one dose for emergency use in February.

"We are in discussions with the Government of India with the objective of starting a bridging clinical study of our Janssen COVID-19 vaccine candidate in India, subject to local regulatory approvals," Johnson & Johnson India spokesperson said in an email reply.

Johnson & Johnson's vaccine can be stored at refrigerator temperatures.

"At Johnson & Johnson, we remain fully focused on bringing a safe and effective COVID-19 vaccine to people around the world, if authorised for use by local health authorities", the spokesperson said.

Published On: Fri, 09 Apr 2021 11:17:48 GMT